Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia

Angela Cheng-Lai

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia'. Together they form a unique fingerprint.

Medicine & Life Sciences